Furthermore, it has been found that METTL14 can inhibit aerobic glycolysis in p53-wild-type colorectal cancer cells by suppressing the expression of SLC2A3 and PGAM1 in an m6A-dependent manner [22]. The gene discussed is TP53; the disease is colorectal cancer.